Loading...
Anlon Healthcare Ltd. IPO Details – Price, Date, GMP & Analysis
Listed
Mainboard
Price Range:
Rs.91.00
Issue Size:
Rs.121.03 Cr
Lot Size:
164 shares
Open Date:
August 26
Anlon Healthcare Ltd. IPO Overview
Bidding Dates
August 26 - August 29
Min Investment
₹14,924
Price Range
₹91.00
Issue Size
₹121.03 Cr
IPO DRHP Doc
Company Overview
Anlon Healthcare Limited, incorporated in 2013, specializes in manufacturing pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company adheres to international standards and offers custom manufacturing for complex chemicals. It has received multiple Drug Master File approvals and has a diverse portfolio of products, ensuring quality through rigorous testing and analysis.
IPO Timeline
Opens
Aug 26
Closes
Aug 29
Allotment
Sep 1
Refunds
Sep 2
Shares Credit
Sep 2
Listing
Sep 3
Opens
Aug 26
Closes
Aug 29
Allotment
Sep 1
Refunds
Sep 2
Shares Credit
Sep 2
Listing
Sep 3
Latest Subscription Data
| Category | Subscription | Status |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 1.07x | Oversubscribed |
| NII (Non-Institutional Investors/HNI) | 10.61x | Oversubscribed |
| RII (Retail Individual Investors) | 47.26x | Oversubscribed |
| Total Subscription | 7.12x | Oversubscribed |
Last updated: Aug 29, 2025, 05:06 PM
Current GMP:
Rs.1
Est. Listing:
Rs.92
Est. Gain:
+1.1%
Star Rating:
★★★★★(1/5)
Financial Information
Financial Data Table
Detailed breakdown of financial metrics across years
| Financial Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Assets | ₹181.3 Cr | ₹128 Cr | ₹111.55 Cr |
| EBITDA | ₹32.38 Cr | ₹15.57 Cr | ₹12.66 Cr |
| Net Worth | ₹80.42 Cr | ₹21.03 Cr | ₹7.37 Cr |
| Profit After Tax | ₹20.52 Cr | ₹9.66 Cr | ₹5.82 Cr |
| Reserves and Surplus | ₹40.57 Cr | ₹5.03 Cr | ₹4.63 Cr |
| Total Borrowing | ₹58.35 Cr | ₹74.56 Cr | ₹66.39 Cr |
| Total Income | ₹120.46 Cr | ₹66.69 Cr | ₹113.12 Cr |
Financial data is visualized in the chart above
Strengths & Risks Analysis
Key Strengths
Competitive advantages and positive aspects
- Diverse product portfolio with scalable business operations.
- Experienced promoters and competent management team.
- High entry barriers due to strict approval standards.
- In-house testing ensures consistent quality and compliance.
- Emphasis on Quality, Environment, Health, and Safety (QEHS).
IPO Details
Anlon Healthcare IPO Details
| ₹10 per share | |
| ₹91 per share | |
| 1,33,00,000 shares (aggregating up to ₹121.03 Cr) | |
| 164 Shares | |
| 3,98,51,500 shares | |
| 5,31,51,500 shares | |
| BSE, NSE | |
| IPO Date | August 26, 2025 to August 29, 2025 |
| Issue Type | Bookbuilding IPO |
| Sale Type | Fresh Capital |
| September 3, 2025 |
Anlon Healthcare IPO Reservation
Share Reservation Distribution
QIB
9,975,000 shares (75%)
HNI (NII)
1,995,000 shares (15%)
bNII (>₹10L)
1,330,000 shares (10%)
Retail
1,330,000 shares (10%)
sNII (<₹10L)
665,000 shares (5%)
Anlon Healthcare IPO Promoter Holding
| Promoter Holding Post Issue | 52.68% |
| Promoter Holding Pre Issue | 70.26% |
Anlon Healthcare IPO Listing Details
| ₹91 per share |
| 544497 |
| AHCL |
| BE |
| INE0Y8W01017 |
| September 3, 2025 |
| T |
Key Dates
Open Date:August 26
Close Date:August 29
Listing Date:September 3
